Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Parker Insider Profile
4 Followers
Anthony Parker, Director at Allergy Therapeutics, holds ― shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Anthony Parker Bought 1,650,000p shares of Allergy Therapeutics on Oct 13, 2023 for an estimated value of 16.50K.
Anthony Parker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Anthony Parker does not currently own shares as a corporate insider.
A breakdown of Anthony Parker's holdings
Insider Roles
Director
Roles that Anthony Parker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Anthony Parker
Anthony Parker's Trading History
List of latest transactions for each holding click on a transaction to see Anthony Parker's performance on stock
You May Also Like
Anthony Parker insider profile FAQ
What is the percentage of profitable transactions made by Anthony Parker?
The percentage of profitable transactions made by Anthony Parker is ―.
What is the average return per transaction made by Anthony Parker?
The average return per transaction made by Anthony Parker is ―.
What stocks does Anthony Parker hold?
Anthony Parker holds: GB:AGY stocks.
What was Anthony Parker’s latest transaction?
Anthony Parker latest transaction was an Informative Buy of 16.50K.
What was Anthony Parker's most profitable transaction?
Anthony Parker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Anthony Parker's role in Allergy Therapeutics?
Anthony Parker's role in Allergy Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.